Head-to-head comparisons of medication uses, side effects, warnings, and more.
Kesimpta (ofatumumab)
Briumvi (ublituximab)
Kesimpta (ofatumumab)
Briumvi (ublituximab)
Summary of Kesimpta vs. Briumvi
Summary for Monoclonal antibody
Prescription only
Kesimpta (ofatumumab) is an injectable medication for adults with relapsing forms of multiple sclerosis (MS). It works as a monoclonal antibody to help lessen MS flare-ups that come and go. Kesimpta (ofatumumab) is injected under the skin. You can use the Kesimpta prefilled syringes or Sensoready Pens to inject. After the first 3 weekly injections, you inject the medication once a month. Some common side effects include a higher risk of infections, pain or swelling at the injection site, and headache.
Summary for Monoclonal antibody
Prescription only
Briumvi (ublituximab or ublituximab-xiiy) is a medication used to treat relapsing forms of multiple sclerosis (MS). This medication is given as an infusion into your veins by a healthcare provider. After you finish the starting doses, you'll receive Briumvi (ublituximab) once every 6 months. Briumvi (ublituximab) can raise your risk for infusion-related reactions so your provider might give you pre-medications, such as a corticosteroid, before your infusion to lower the risk of these reactions.